Regulation of Neurotoxin Production and Sporulation by a Putative agrBD Signaling System in Proteolytic Clostridium botulinum

被引:86
作者
Cooksley, Clare M. [1 ]
Davis, Ian J. [1 ]
Winzer, Klaus [1 ]
Chan, Weng C. [2 ]
Peck, Michael W. [3 ]
Minton, Nigel P. [1 ]
机构
[1] Univ Nottingham, Ctr Biomol Sci, Sch Mol Med Sci, Nottingham NG7 2RD, England
[2] Univ Nottingham, Ctr Biomol Sci, Sch Pharm, Nottingham NG7 2RD, England
[3] Inst Food Res, Norwich NR4 7UA, Norfolk, England
基金
英国生物技术与生命科学研究理事会;
关键词
SOLVENT PRODUCTION; GENE-EXPRESSION; DOWN-REGULATION; HALL-A; TOXIN; DIFFICILE; OVEREXPRESSION; TRANSDUCTION; LOCUS; LEADS;
D O I
10.1128/AEM.03038-09
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
A significant number of genome sequences of Clostridium botulinum and related species have now been determined. In silico analysis of these data revealed the presence of two distinct agr loci (agr-1 and agr-2) in all group I strains, each encoding putative proteins with similarity to AgrB and AgrD of the well-studied Staphylococcus aureus agr quorum sensing system. In S. aureus, a small diffusible autoinducing peptide is generated from AgrD in a membrane-located processing event that requires AgrB. Here the characterization of both agr loci in the group I strain C. botulinum ATCC 3502 and of their homologues in a close relative, Clostridium sporogenes NCIMB 10696, is reported. In C. sporogenes NCIMB 10696, agr-1 and agr-2 appear to form transcriptional units that consist of agrB, agrD, and flanking genes of unknown function. Several of these flanking genes are conserved in Clostridium perfringens. In agreement with their proposed role in quorum sensing, both loci were maximally expressed during late-exponential-phase growth. Modulation of agrB expression in C. sporogenes was achieved using antisense RNA, whereas in C. botulinum, insertional agrD mutants were generated using ClosTron technology. In comparison to the wild-type strains, these strains exhibited drastically reduced sporulation and, for C. botulinum, also reduced production of neurotoxin, suggesting that both phenotypes are controlled by quorum sensing. Interestingly, while agr-1 appeared to control sporulation, agr-2 appeared to regulate neurotoxin formation.
引用
收藏
页码:4448 / 4460
页数:13
相关论文
共 40 条
[1]  
[Anonymous], 1989, Molecular Cloning: A Laboratory
[2]   Effects of Carbon Dioxide on Growth of Proteolytic Clostridium botulinum, Its Ability To Produce Neurotoxin, and Its Transcriptome [J].
Artin, Ingrid ;
Mason, David R. ;
Pin, Carmen ;
Schelin, Jenny ;
Peck, Michael W. ;
Holst, Elisabet ;
Radstrom, Peter ;
Carter, Andrew T. .
APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 2010, 76 (04) :1168-1172
[3]  
ARVIDSON SO, 1983, STAPHYLOCOCCI STAPHY, V2, P745
[4]   Identification of the agr locus of Listeria monocytogenes:: Role in bacterial virulence [J].
Autret, N ;
Raynaud, C ;
Dubail, I ;
Berche, P ;
Charbit, A .
INFECTION AND IMMUNITY, 2003, 71 (08) :4463-4471
[5]   Regulation of neurotoxin complex expression in Clostridium botulinum strains 62A, Hall A-hyper, and NCTC 2916 [J].
Bradshaw, M ;
Dineen, SS ;
Maks, ND ;
Johnson, EA .
ANAEROBE, 2004, 10 (06) :321-333
[6]   Independent evolution of neurotoxin and flagellar genetic loci in proteolytic Clostridium botulinum [J].
Carter, Andrew T. ;
Paul, Catherine J. ;
Mason, David R. ;
Twine, Susan M. ;
Alston, Mark J. ;
Logan, Susan M. ;
Austin, John W. ;
Peck, Michael W. .
BMC GENOMICS, 2009, 10
[7]   Expression of botulinum neurotoxins A and E, and associated non-toxin genes, during the transition phase and stability at high temperature: analysis by quantitative reverse transcription-PCR [J].
Couesnon, A ;
Raffestin, S ;
Popoff, MR .
MICROBIOLOGY-SGM, 2006, 152 :759-770
[8]  
Davis TO, 2000, J MOL MICROB BIOTECH, V2, P59
[9]  
Desai RP, 1999, APPL ENVIRON MICROB, V65, P936
[10]   Metabolic Flux Analysis Elucidates the Importance of the Acid-Formation Pathways in Regulating Solvent Production by Clostridium acetobutylicum [J].
Desai, Ruchir P. ;
Harris, Latonia M. ;
Welker, Neil E. ;
Papoutsakis, Eleftherios T. .
METABOLIC ENGINEERING, 1999, 1 (03) :206-213